X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/11/2911674/0/en/OKYO-Pharma-to-Initiate-Neuropathic-Corneal-Pain-Trial-for-OK-101.html
https://okyopharma.com/okyo-pharma-announces-promising-categorical-data-from-ok-101-phase-2-trial-in-dry-eye-disease/
https://www.globenewswire.com/news-release/2024/07/10/2911000/0/en/OKYO-Pharma-Announces-Promising-Categorical-Data-from-OK-101-Phase-2-Trial-in-Dry-Eye-Disease.html
https://www.globenewswire.com/news-release/2024/05/08/2877673/0/en/OKYO-Pharma-Announces-Participation-in-May-2024-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/04/30/2872038/0/en/OKYO-Pharma-Announces-Upcoming-Presentation-of-OK-101-Phase-2-Data-for-Dry-Eye-Disease-at-the-Dry-Horizons-Symposium-a-Partner-Meeting-of-the-Association-for-Research-in-Vision-and.html
https://www.globenewswire.com/news-release/2024/04/08/2859659/0/en/OKYO-Pharma-to-Reschedule-Key-Opinion-Leader-Event-in-Dry-Eye-Disease-to-May-2024.html
https://www.globenewswire.com/news-release/2024/04/02/2855774/0/en/OKYO-Pharma-Announces-Upcoming-Presentation-of-OK-101-Phase-2-Data-for-Dry-Eye-Disease-at-Eyecelerator-2024-a-Partner-Meeting-of-the-American-Society-for-Cataract-and-Refractive-Su.html
https://www.globenewswire.com/news-release/2024/03/21/2850094/0/en/OKYO-Pharma-to-Host-Key-Opinion-Leader-Event-to-Discuss-New-and-Comprehensive-Data-from-Phase-2-Dry-Eye-Disease-Trial.html
https://www.globenewswire.com//news-release/2024/02/09/2826710/0/en/OKYO-Pharma-Receives-FDA-Approval-of-IND-for-OK-101-in-Neuropathic-Corneal-Pain.html
https://www.globenewswire.com/news-release/2024/01/31/2820967/0/en/OKYO-Pharma-Announces-Distinguished-Ophthalmologists-with-Expertise-in-the-Medical-and-Surgical-Treatment-of-Ocular-Surface-Diseases-Join-its-Scientific-Advisory-Board.html
Market Place
Share 
